DRMAW Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 16:00):

Stats
Today's Volume	1 101.00
Average Volume	0.00
Market Cap	1.70M
EPS	$-0.539 ( 2023-09-29 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-04	Mento Steven J	Buy	10 000	Stock Option (Right to Buy)
2024-01-04	Proehl Gerald T	Buy	125 000	Stock Option (right to buy)
2024-01-04	Fisher Mary	Buy	10 000	Stock Option (Right to Buy)
2024-01-04	Scott Kathleen D.	Buy	10 000	Stock Option (Right to Buy)
2024-01-04	Sandler Andrew Seth	Buy	10 000	Stock Option (Right to Buy)

INSIDER POWER
100.00
Last 29 transactions
Buy: 1 007 127 \| Sell: 0

Dermata Therapeutics, Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Dermata Therapeutics, Financials

Annual	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-39.98

FY	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-39.98

FY	2022
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-13.92

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$0

Financial Reports:

No articles found.

Dermata Therapeutics, Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Dermata Therapeutics,

Dermata Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the treatment of medical and aesthetic skin conditions. The company\'s lead product candidate is DMT310, a once-weekly topical product that is under clinical development for the treatment of acne vulgaris, psoriasis vulgaris, and papulopustular rosacea. It is also developing DMT410 for the treatment of hyperhidrosis and aesthetic conditions. The company was founded in 2014 and is headquartered in San Diego, California.